Comvita will take a 19.9 per cent stake in Nelson company SeaDragon, giving the Bay of Plenty honey firm a secure supply of fish oil for a planned expansion of its range of health supplements.
Chairman Neil Craig said Comvita had long believed New Zealand fish oils could command a premium in international markets as the region was synonymous with clean, deep, blue oceans and high quality primary sector exports.
"Omega-3 fish oils have become a core ingredient platform for Comvita but, until now, we have not been able to consistently source local supply to establish a unique New Zealand-sourced range," he said. "SeaDragon, as New Zealand's largest refiner and blender producer of high quality fish oils, provides Comvita with long-term security of supply."
Comvita has agreed to participate in the shortfall bookbuild associated with SeaDragon's three-for-five rights offer, which is targeting a maximum of $9.09 million. The Comvita commitment, combined with $2.5 million already committed by SeaDragon's 21.8 per cent shareholder BioScience Managers, and other acceptances, will provide SeaDragon in excess of $7.5 million.
Each right entitles an investor to one share and one option. Comvita will invest between $2 million and $3.2 million, depending on the uptake, and will be scaled to ensure they reach their 19.9 per cent stake. Comvita will also be granted an option to buy three million shares at 0.8c each before October 1, 2017, subject to shareholder approval.